Research map: Baseline Anemia and Short Dual Antiplatelet Therapy in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention

Back to the article

Papers in this map

  1. Clinical End Points in Coronary Stent Trials · Donald E. Cutlip · 2007 · 5526 citations · Cited by this paper
  2. Anaemia in percutaneous coronary intervention: more than a bleeding risk criterion · Andrea Rubboli · 2026 · Cites this paper
  3. The role of lipoprotein (a) in premature cardiovascular disease: primed for prevention · 2026 · Related
  4. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials · Francesco Costa · 2017 · 1190 citations · Cited by this paper
  5. Interplay of HDL cholesterol and apoB and the risk of incident atherosclerotic cardiovascular disease in UK Biobank · 2026 · Related
  6. Ticagrelor with or without Aspirin in High-Risk Patients after PCI · Roxana Mehran · 2019 · 1037 citations · Cited by this paper
  7. Rheumatoid arthritis and risk of myocardial infarction: A nationwide cohort study · 2026 · Related
  8. Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI · Hirotoshi Watanabe · 2019 · 859 citations · Cited by this paper
  9. Beyond Survival: The Eriksen Case and the Dilemma of Elite Sport Participation After Sudden Cardiac Arrest · 2026 · Related
  10. Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention · Philip M. Urban · 2019 · 828 citations · Cited by this paper
  11. Cardiovascular prevention in childhood and young adults · 2026 · Related
  12. Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk · Marco Valgimigli · 2021 · 590 citations · Cited by this paper
  13. Rethinking how we characterize the exercise blood pressure response in athletes · 2026 · Related
  14. Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents · Usman Baber · 2016 · 557 citations · Cited by this paper
  15. Navigating Clinical Likelihood and Cardiovascular Risk over a Lifetime Course of Coronary Artery Disease · 2026 · Related
  16. Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary Stenting · Francesco Costa · 2019 · 325 citations · Cited by this paper
  17. Safe hearts need a healthy environment: prevention beyond our clinic walls · 2026 · Related
  18. Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome · Hirotoshi Watanabe · 2022 · 324 citations · Cited by this paper
  19. Multidisciplinary cardiac rehabilitation—an indispensable therapeutic intervention when starting a GLP-1 receptor agonist therapy? · 2026 · Related
  20. Antiplatelet therapy after percutaneous coronary intervention · Dominick Joseph Angiolillo · 2022 · 295 citations · Cited by this paper
  21. Pharmacological risk stratification of Lp(a): diabetes status may refine residual cardiovascular risk beyond ASCVD history · 2026 · Related
  22. Iron deficiency and cardiovascular disease · Gianluigi Savarese · 2022 · 203 citations · Cited by this paper
  23. Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial · Zhen Ge · 2024 · 181 citations · Cited by this paper
  24. Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials · Francesco Costa · 2022 · 138 citations · Cited by this paper
  25. Iron Deficiency in Adults · Michael Auerbach · 2025 · 132 citations · Cited by this paper
  26. Prognostic Implications of Declining Hemoglobin Content in Patients Hospitalized With Acute Coronary Syndromes · Sergio Leonardi · 2021 · 129 citations · Cited by this paper
  27. 3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation · Roxana Mehran · 2021 · 103 citations · Cited by this paper
  28. Evolution of antithrombotic therapy in patients undergoing percutaneous coronary intervention: a 40-year journey · Davide Cao · 2020 · 97 citations · Cited by this paper
  29. Meta-Analysis of the Prognostic Impact of Anemia in Patients Undergoing Percutaneous Coronary Intervention · Chun Shing Kwok · 2016 · 83 citations · Cited by this paper
  30. Association of Anemia With Outcomes Among ST-Segment–Elevation Myocardial Infarction Patients Receiving Primary Percutaneous Coronary Intervention · Nima Moghaddam · 2018 · 63 citations · Cited by this paper
  31. Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study · Gennaro Giustino · 2016 · 47 citations · Cited by this paper
  32. Impact of Baseline Anemia in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A Prespecified Analysis From the VALIDATE‐SWEDEHEART Trial · Axel Wester · 2019 · 44 citations · Cited by this paper
  33. Design and rationale of the XIENCE short DAPT clinical program: An assessment of the safety of 3-month and 1-month DAPT in patients at high bleeding risk undergoing PCI with an everolimus-eluting stent · Marco Valgimigli · 2020 · 35 citations · Cited by this paper
  34. Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention · Michela Faggioni · 2019 · 31 citations · Cited by this paper
  35. Preserving and Promoting Clinical Trial Representativeness · Francesca Maria Di Muro · 2025 · 17 citations · Cited by this paper
  36. Prognostic impact of neutrophil-to-lymphocyte ratio in patients with and without diabetes mellitus undergoing percutaneous coronary intervention · Francesca Maria Di Muro · 2025 · 7 citations · Cited by this paper
  37. Long-Term Safety and Efficacy of Prolonged Dual Antiplatelet Therapy according to Baseline Anemia after Percutaneous Coronary Intervention · Hun-Tae Kim · 2022 · 5 citations · Cited by this paper
  38. Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trial · Alessandro Spirito · 2023 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)